Through pop-up clinics held at a London school, Crick scientists are investigating the growing overlap of hepatitis B and metabolic liver disease.

Europe is set to miss the WHO target to eliminate viral hepatitis as a public health threat by 2030 despite progress in screening because of gaps in vaccination and reaching key populations, according...

England is on track to become one of the first countries in the world to eliminate hepatitis C, a dangerous virus that attacks the liver, figures show.

Our findings provide the first robust national-level evidence, albeit observational, that high HPV vaccination coverage is associated with a substantial reduction in cervical cancer deaths. This is sh...

An exciting shift is underway in progress towards tackling HIV as a global public health threat, as we enter a new era of nucleotide and nucleoside reverse transcriptase inhibitor (NRTI)-free dual reg...

BRATISLAVA, June 9 (IPS) - As South Africa officially launches the rollout of a groundbreaking HIV prevention drug, civic groups in the country have slammed the plan, saying it will not reach anywhere near enough people.

New research from the Clinton Health Access Initiative shows declines in HIV testing and in people accessing oral prevention services.

Hepatitis B virus (HBV) and hepatitis C virus (HCV) remain public health threats in the WHO European region, where an estimated 29 million people live with chronic infection and viral hepatitis-relate...